BCWORLD PHARM. Co., Ltd.

KOSDAQ 200780.KQ

BCWORLD PHARM. Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 42.44%

BCWORLD PHARM. Co., Ltd. Gross Profit Margin is 42.44% for the year ending December 31, 2023, a 27.58% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

BCWORLD PHARM. Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 33.26%, a 7.50% change year over year.
BCWORLD PHARM. Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 30.95%, a 8.14% change year over year.
BCWORLD PHARM. Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 28.62%, a -11.92% change year over year.
BCWORLD PHARM. Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 32.49%, a -15.43% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

KOSDAQ: 200780.KQ

BCWORLD PHARM. Co., Ltd.

CEO	Mr. Sung-Han Hong
IPO Date	Dec. 15, 2014
Location	South Korea
Headquarters	22 Geumto-ro 40beon-gil
Employees	284
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberculosis drugs, anti-emetic, antiviral drugs, antibiotic, anti-malignant tumor drugs, antifungal agent, antihistamines, antidote, and antipyretic/analgesic/anti-inflammatory. BCWORLD PHARM. Co., Ltd. was founded in 1980 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years